Nitrogen

Description

Nitrogen, Compressed NF, is a high-pressure gas classified under UN1066 and is available by prescription only. It is essential to handle this gas with caution due to the risk of rapid suffocation and death without warning. Proper storage and usage require securing the cylinder and ensuring adequate ventilation. Equipment used must be rated for cylinder pressure, and the cylinder temperature must not exceed 125°F (52°C). The valve should be closed after each use and when the cylinder is empty, and it should be returned with a minimum pressure of 25 PSIG.

Nitrogen should be administered in accordance with the Material Safety Data Sheet. In case of inhalation, the individual should be removed to fresh air, and if not breathing, artificial respiration should be provided. If breathing is difficult, oxygen should be administered, and a physician should be contacted. The administration of Nitrogen may pose hazards or contraindications and should only be performed by or under the supervision of a licensed practitioner experienced in its use. This practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Federal law prohibits dispensing this product without a prescription. It is produced by Air Liquefaction, and it is critical to avoid using oil on valves or connections. Transfilling of this gas is strictly prohibited.

Uses and Indications

This drug is indicated for use in specific medical situations where the administration of Nitrogen is deemed necessary. It is essential that this drug be administered only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrogen. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the potential hazards associated with Nitrogen administration, which may render it contraindicated in certain circumstances. There are no specific teratogenic or nonteratogenic effects reported for this drug.

Dosage and Administration

Administration of Nitrogen is to be conducted via the respiratory route through inhalation. The active ingredient is provided in a concentration of 99.5 L of Nitrogen per 1 L of the delivery system.

It is imperative that the administration of Nitrogen is performed by or under the supervision of a licensed practitioner who possesses experience in the use and administration of this gas. This ensures that the procedure is conducted safely and effectively, adhering to established medical guidelines.

Contraindications

Administration of Nitrogen is contraindicated in patients who are not under the supervision of a licensed practitioner experienced in its use. The use of Nitrogen is restricted to those familiar with its indications, effects, dosages, methods, frequency, duration of administration, and associated hazards, contraindications, side effects, and necessary precautions.

Additionally, the removal of the product label is prohibited. Caution must be exercised to avoid the application of oil on valves or connections, as this may pose safety risks. Transfilling of this gas is also strictly prohibited.

Warnings and Precautions

CAUTION is advised when handling high-pressure gas, as it can lead to rapid suffocation and death without warning. The administration of Nitrogen may pose hazards or be contraindicated; therefore, it should only be performed by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrogen. This practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

General precautions must be observed to ensure safe handling and use of Nitrogen. Cylinders should be secured and stored in well-ventilated areas. It is imperative to utilize equipment that is rated for the cylinder pressure. The temperature of the cylinder must not exceed 125°F (52°C). After each use and when the cylinder is empty, the valve should be closed. Cylinders should be returned with a minimum pressure of 25 PSIG. All handling must be conducted in accordance with the Material Safety Data Sheet. It is critical to avoid the use of oil on valves or connections, and the transfilling of this gas is strictly prohibited.

In the event of inhalation, immediate first aid measures should be taken. The individual should be removed to fresh air. If the person is not breathing, artificial respiration should be administered. If breathing difficulties arise, oxygen should be provided. A physician should be contacted promptly for further evaluation and care.

Side Effects

Patients receiving nitrogen should be aware of the potential hazards associated with its administration. The use of nitrogen carries a significant risk, as it is classified as a high-pressure gas that can lead to rapid suffocation and death without warning.

Due to these serious risks, caution is advised when considering the administration of nitrogen, as it may be hazardous or contraindicated in certain situations. It is essential for healthcare providers to evaluate the appropriateness of nitrogen use in each individual case to mitigate the potential for adverse reactions.

Drug Interactions

The administration of Nitrogen is associated with potential hazards and contraindications. It is imperative that Nitrogen is used exclusively by or under the supervision of a licensed practitioner who possesses experience in its use and administration. This practitioner should be well-versed in the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Due to the complexities involved in the administration of Nitrogen, careful monitoring and adherence to established guidelines are essential to ensure patient safety and therapeutic efficacy.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

There is no specific pediatric use information available for this medication, including recommended ages, dosing differences, safety concerns, or special precautions for children. Healthcare professionals should exercise caution when considering the use of this medication in pediatric patients due to the absence of relevant data.

Geriatric Use

There is no specific information regarding the use of Nitrogen in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as the absence of data necessitates careful consideration of individual patient factors and potential risks. Monitoring for any adverse effects or changes in response to treatment is advisable in this population.

Pregnancy

Administration of Nitrogen is contraindicated in pregnancy due to potential risks to fetal outcomes. Pregnant patients should avoid exposure to Nitrogen, as its use may pose hazards that could adversely affect both maternal and fetal health. Healthcare professionals are advised to counsel women of childbearing potential regarding the risks associated with Nitrogen and to consider alternative options that are safer during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of nitrogen in lactating mothers. Additionally, there is no information available about the potential for excretion of nitrogen in breast milk or any associated risks to breastfed infants during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of overdosage, it is critical to recognize the potential hazards associated with high-pressure gas, particularly Nitrogen. The administration of Nitrogen can lead to rapid suffocation and death without warning. Therefore, utmost caution is advised.

Healthcare professionals must be aware that the use of Nitrogen is only recommended under the supervision of a licensed practitioner who possesses experience in its administration. This includes a thorough understanding of the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

In cases of suspected overdosage, immediate medical intervention is essential. Practitioners should ensure that appropriate emergency measures are in place and that the patient is monitored closely for any signs of respiratory distress or other adverse effects. Prompt recognition and management of symptoms are vital to mitigate the risks associated with Nitrogen overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No specific postmarketing experience details have been reported. As such, there are no additional adverse events or rare case reports to summarize at this time.

Patient Counseling

Healthcare providers should advise patients of the potential hazards associated with the use of high-pressure gas, specifically noting that it can cause rapid suffocation and death without warning. It is essential to secure the gas cylinder properly and ensure adequate ventilation during both storage and use.

Patients should be instructed to use the gas only with equipment that is rated for the cylinder pressure. Additionally, they must be made aware that the cylinder temperature should not exceed 125°F (52°C). After each use and when the cylinder is empty, patients should close the valve to prevent any accidental release of gas. It is important to return the cylinder with at least 25 PSIG pressure.

Patients must utilize the gas in accordance with the Material Safety Data Sheet provided. In the event of inhalation, they should be instructed to remove themselves to fresh air immediately. If the patient is not breathing, they should be given artificial respiration, and if breathing is difficult, oxygen should be administered. It is crucial to call a physician in such situations.

Healthcare providers should emphasize that the administration of nitrogen may be hazardous or contraindicated and should only be performed by or under the supervision of a licensed practitioner experienced in its use. This practitioner should be familiar with the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Patients should be cautioned that federal law prohibits dispensing this product without a prescription. They must also be informed that oil should not be used on the valve or connections, and that transfilling of this gas is prohibited. Finally, patients should be advised not to remove the product label, as it contains important safety information.

Storage and Handling

The product is supplied in secure cylinders, which must be stored in a well-ventilated area to ensure safety during both storage and use. It is critical that the temperature of the cylinders does not exceed 125°F (52°C) to maintain product integrity.

After each use, the valve should be closed, and cylinders should be returned with a minimum pressure of 25 PSIG. Additionally, handling and usage of the product must be conducted in accordance with the Material Safety Data Sheet to ensure proper safety protocols are followed.

Additional Clinical Information

The route of administration for the medication is via respiratory inhalation. Clinicians should be aware that the administration of Nitrogen may pose hazards or be contraindicated. It is essential that this medication is used only by or under the supervision of a licensed practitioner who has experience with Nitrogen administration. This practitioner should be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrogen as submitted by J & M CYLINDER GASES, INC.. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)